Trials / Conditions / KRAS G12R
KRAS G12R
4 registered clinical trials studyying KRAS G12R — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies NCT05786924 | Institut de Recherches Internationales Servier | Phase 1 / Phase 2 |
| Active Not Recruiting | A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors NCT05726864 | Elicio Therapeutics | Phase 1 / Phase 2 |
| Completed | A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumor NCT04853017 | Elicio Therapeutics | Phase 1 |
| Available | Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma NCT07083479 | Elicio Therapeutics | — |